TickerFactsScreenerDevelopers

Cytosorbents Corp (CTSO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$2.48M2011: -$3.83M2012: -$3.62M2013: -$3.49M2014: -$6.66M2015: -$9.05M2016: -$6.73M2017: -$6.46M2018: -$10.84M2019: -$16.76M2020: -$5.61M2021: -$14.01M2022: -$28.23M2023: -$21.66M2024: -$14.43M2025: -$12.38M-$12.38M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$12.38M+14.2%
2024-$14.43M+33.4%
2023-$21.66M+23.3%
2022-$28.23M-101.6%
2021-$14.01M-149.5%
2020-$5.61M+66.5%
2019-$16.76M-54.6%
2018-$10.84M-67.8%
2017-$6.46M+4.0%
2016-$6.73M+25.6%
2015-$9.05M-35.8%
2014-$6.66M-90.9%
2013-$3.49M+3.5%
2012-$3.62M+5.5%
2011-$3.83M-54.5%
2010-$2.48M—